Skip to main content

Security report for inovaceprozivot.cz

Neofema s.r.o. · Healthcare · Czech Republic

Medium risk. 7 critical or high findings in Security headers, GDPR outside view and 3 other checks.

Security score

53/100

Risk levelMedium

0–100, higher is better. How it is calculated

The website inovaceprozivot.cz is a Czech healthcare advocacy platform operated by Neofema s.r.o., focusing on promoting innovative medicines and their benefits in reducing healthcare and social system costs. The site targets healthcare stakeholders, patients, and policymakers within the Czech Republic, providing study results and information to support healthcare innovation. The business is relatively young, founded in 2019, and operates in a niche healthcare advocacy sector. Technically, the site uses a custom CMS with common JavaScript libraries such as jQuery, Swiper, and Fancybox, and is hosted by Forpsi. It employs Google Tag Manager and Cookiehub for analytics and cookie consent, respectively. The website is mobile-optimized with good SEO and accessibility basics but lacks some advanced accessibility features.

Scanned

NIS2 and GDPR posture

GDPR outside view
68/ 100 · Medium
Checks completed
7of 7

NIS2 Art. 21(2)

  1. (a) Risk analysis and security policies: Not visible from outside
  2. (b) Incident handling: One indicator
  3. (c) Business continuity, backups and crisis management: Not visible from outside
  4. (d) Supply chain security: Not visible from outside
  5. (e) Secure acquisition, development and maintenance, including vulnerability handling: Partly checked
  6. (f) Assessing the effectiveness of security measures: Not visible from outside
  7. (g) Cyber hygiene and security training: Not visible from outside
  8. (h) Cryptography and encryption: Partly checked
  9. (i) HR security, access control and asset management: One indicator
  10. (j) Multi-factor authentication and secured communications: Not visible from outside

This scan rated NIS2 with an earlier keyword method that is no longer shown; rescan for the per-article view. Risk management, continuity, supply chain, training, MFA, management oversight (Art. 20) and incident reporting (Art. 23) need internal evidence, and Guard cannot tell whether NIS2 applies to this organisation.

GDPR is indicative only, based on publicly visible signals: Articles 7, 12, 13 and 32 of Regulation (EU) 2016/679 and Article 5(3) of the ePrivacy Directive. Not a certification or legal assessment.

Priority findings

7 findings rated critical or high. Fix these first.

  1. Security headers

    Security headers are instructions your web server sends to every visitor’s browser. Missing ones leave visitors more exposed to attacks such as clickjacking and injected scripts.

    • High

      Missing Strict-Transport-Security header

      Forces HTTPS connections

      What to do: Add "Strict-Transport-Security: max-age=31536000; includeSubDomains; preload"

      • CWE-319
      • OWASP A04:2025
      • ASVS V3.4.1
    • High

      Missing X-Frame-Options header

      Prevents clickjacking attacks

      What to do: Add "X-Frame-Options: DENY" or "X-Frame-Options: SAMEORIGIN"

    • High

      Missing Content-Security-Policy header

      Controls resources the browser is allowed to load

      What to do: Implement a Content-Security-Policy appropriate for your application

      • ASVS V3.4.3
      • OWASP Secure Headers: OWASP Secure Headers Project recommends Content-Security-Policy: default-src 'self'; form-action 'self'; base-uri 'self'; object-src 'none';…

  2. GDPR outside view

    These are the privacy signals visitors and data protection authorities look for under GDPR.

    • High

      No Cookie Consent Banner found

      GDPR requires explicit consent for non-essential cookies

      What to do: Implement a cookie consent banner that appears on first visit

  3. Email security

    SPF, DKIM and DMARC stop others sending email that looks like it comes from your domain, a common route to phishing and invoice fraud.

    • High

      No DMARC record found

      DMARC provides email authentication and reporting

      What to do: Add DMARC record: "v=DMARC1; p=none; rua=mailto:dmarc@yourdomain.com"

Need hands-on remediation? Email guard@offseq.com

Keep watching inovaceprozivot.cz

This scan found 21 issues across 6 checks. Monitoring re-runs those checks daily, emails you when something material changes and records each fix, so you can show progress.

Daily monitoring

Recommended

€25per month

  • TLS certificates and expiry
  • DNS records
  • SPF, DKIM and DMARC
  • Security headers
  • GDPR and NIS2 posture
  • Exposed services
  • Third-party trackers
  • Security score drift

Email alerts on material changes and an exportable JSON history of every change.

Billed monthly to your card. Cancel anytime. See sample alerts.

Full report

€39.90one-time

  • The complete analysis as a PDF you can cite
  • Email delivery with an unlock code
  • Lifetime access to this report

Prices incl. 21% VAT. Secure checkout by Mollie; sold by SEQ SIA, Latvia.

Results by check

Each check with its score, findings and the evidence it collected.

How this score is calculated

The security score runs 0–100, higher is better. It is the plain average of the security checks that completed in this scan, each counted equally. A check that could not run is left out: it counts neither as a pass nor as a fail.

Counted in this score

SSL/TLS
62
Security headers
20
Email security
65
DNS health
85
Network security
20
GDPR outside view
68
Average
53

Not counted

  • NIS2 outside view: Re-weights evidence from the TLS, email, DNS, network and hygiene checks, so counting it would count that evidence twice. Shown on its own.
  • OffSeq Observations: An AI reading of the site, useful context but not reproducible evidence. Shown on its own.

Findings that cap the score at 49

Each of these is serious on its own, so while any is present the site cannot rate better than high risk, however good the other checks are.

  • The certificate is not trusted by browsers
  • The website is not served over HTTPS
  • A database, remote desktop, file-sharing or Telnet service is reachable from the internet
  • The page loads a script from a compromised source
  • The domain registration has expired
  • SPF authorises every server to send mail as the domain

Partial scans

When the site blocks Guard or most checks cannot run, the score covers only the checks that ran (usually DNS and email), is capped at 75 and is shown as partial, without a risk level.

Risk levels

  • Critical0–25
  • High26–49
  • Medium50–75
  • Low76–100

Breach exposure

Leaked credentials and lookalike domains from OffSeq Breach. The counts are free; the detailed lists are paid add-ons.

Dark web exposure

Add-on

Leaked records that mention inovaceprozivot.cz, from OffSeq Breach.

No leaked records found

Breach holds no records for inovaceprozivot.cz right now. New leaks arrive continuously, so monitoring on Breach alerts you if that changes.

Monitor on Breach (opens in a new tab)

Technical appendix

Business context, site observations and technical notes gathered during the scan, and the standards behind each reference.

Business context

Business profile

Neofema s.r.o. positions itself as an important player in healthcare innovation advocacy in the Czech Republic. The business model revolves around information dissemination and influencing healthcare policy through study results and patient stories. The website content is professional and consistent with the company's mission. There is no evidence of direct commercial transactions or e-commerce. The company appears to maintain a focused partnership ecosystem, though no explicit partner domains were identified. Growth indicators are limited due to the niche focus and relatively recent domain registration.

Security posture

The website benefits from HTTPS encryption and implements cookie consent mechanisms, indicating awareness of privacy and security requirements. However, it lacks explicit security headers such as Content Security Policy (CSP), HSTS, and X-Frame-Options, which are recommended to enhance security posture. No exposed sensitive data or vulnerable libraries were detected in the provided content. The absence of explicit contact information for incident response or security policies is a gap. Overall, the security maturity is moderate, with room for improvement in headers and documented policies.

Recommendations

  1. Implement and publish a comprehensive privacy policy and terms of service to improve compliance and user trust.
  2. Add explicit contact information including emails and phone numbers for general and security incident reporting.
  3. Deploy security headers such as CSP, HSTS, and X-Frame-Options to strengthen defense against common web attacks.
  4. Conduct regular security audits and vulnerability scans, especially for third-party JavaScript libraries.
  5. Enhance accessibility features to meet higher standards and improve user experience for all visitors.
Site observations

Automated reading of the public site. Ratings are indicative.

Business

Company
Neofema s.r.o.
Description
Investice, která se vyplatí. Inovativní léčiva dokáží snižovat náklady zdravotního i sociálního systému. Stojí za prodloužením a zkvalitněním života tisíců pacientů.
Key services
Information dissemination, Study results presentation, Healthcare innovation advocacy
Content quality
good
Branding
consistent

Technology

Stack
jQuery, Swiper, Fancybox, RateYo, Google Tag Manager, Cookiehub
Performance
moderate
Mobile
good
Accessibility
basic
SEO
good

Security

Observed score
75/100
Good practices seen
  • HTTPS enabled
  • Cookie consent mechanism
  • Google Tag Manager for analytics

Analytics and tracking

Services
Google Analytics (via Google Tag Manager)
Tracking level
moderate
Privacy practices
basic

Advertising

Tracking pixels
Cookiehub
Transparency
basic

Site quality

Design
good
User experience
good
Content relevance
good
Navigation
good
Professionalism
good
Trustworthiness
moderate

Key observations

  1. Website is in Czech language targeting Czech healthcare sector
  2. No explicit privacy or terms pages found
  3. Cookie consent implemented via Cookiehub
  4. Uses Google Tag Manager for analytics and marketing
  5. WHOIS data is transparent and consistent with business
  6. No suspicious or malicious indicators detected
  7. Website content is professional and focused on healthcare innovation
  8. No contact emails or phone numbers explicitly found in content
  9. No social media links detected in provided HTML
Technical notes

Notes

The website uses a custom CMS with a modern JavaScript stack including jQuery, Swiper, and Fancybox. Google Tag Manager and Cookiehub are integrated for analytics and cookie management. Hosting is provided by Forpsi, a known Czech hosting provider. The site is mobile-optimized and SEO-friendly with proper meta tags and Open Graph data. Performance is moderate, with potential improvements in load times and resource optimization. No CMS name was detected, suggesting a custom or less common platform. Technical debt appears low but could be reduced by adopting modern security headers and improving accessibility compliance.
Standards and sources

Reference chips under each finding point to the standard, regulation or specification the finding relates to. They are taken from the official datasets below and mapped conservatively: a finding with no defensible link shows none. NIS2 and GDPR references mark where a finding is relevant evidence, not a compliance verdict. Implementing Regulation (EU) 2024/2690 binds digital infrastructure and digital service providers; for other entities it is the most detailed public reading of the Article 21 measures. WCAG, EN 301 549, European Accessibility Act and Web Accessibility Directive references name the requirement an automated accessibility rule relates to; they are not a conformance verdict.

Retrieved 2026-10-25

Reviews of this site

Share your experience with inovaceprozivot.cz. Every review is verified by email and published after moderation.

Overall rating
Select a rating
4000 characters remaining

We’ll email you to confirm your review and keep your details private.

Community rating

No published reviews yet. Be the first to review inovaceprozivot.cz.

Feedback on this report

Rate this report, add an optional comment, and tell us if you want a security specialist to follow up.

Overall report quality
Select a rating
2000 characters remaining

We only use your feedback to improve Guard reports. Contact details are never shared.